LSE:NIOX (NIOX Group Plc)
About NIOX
Niox Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis and management of asthma. It offers NIOX VERO, a non-invasive point-of-care system that provides fractional exhaled nitric oxide (FeNO) measurements. The company was founded by Steven Harris and Charles Stuart Webb Swingland on May 19, 2006 and is headquartered in Oxford, the United Kingdom.
NIOX Group Plc (LSE: NIOX) Latest News
Investing Articles
Are Royal Mail plc, AG Barr plc and Circassia Pharmaceuticals plc set to soar by 20%+?
Investing Articles
Should You Buy Hikma Pharmaceuticals Plc, Circassia Pharmaceuticals PLC & Hutchison China MediTech Limited On Today’s News?
Investing Articles
Are Vectura Group PLC And Circassia Pharmaceuticals PLC Better Buys Than GlaxoSmithKline plc?
Investing Articles
Should You Follow Neil Woodford And Buy GlaxoSmithKline plc, AstraZeneca plc, Circassia Pharmaceuticals PLC, Oxford Pharmascience Group Plc And ReNeuron Group Plc?
❮2